The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)Bartosz Wasąg, Peter Vandenberghe|Haematologica|2011Cited by 61
Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer PatientsAnna Ronowicz, Arkadiusz Piotrowski, Jarosław Skokowski et al.|Human Mutation|2015Cited by 18